ARCHIVES

Monoclonal Antibody Improves AML Response To Therapy

This article is from The Cancer Letter archive.

Vol. 25 No. 7 | July 26, 2002

Download PDF Visit The Full Archive

Related Articles

NCI blocked groups from phase III Iressa studies.

April 30, 2004

In Brief: Caplan Receives NSB Public Service Award

March 28, 2014

Radium Society To Meet In L.A.

March 2, 1979

DRCCA Board Approves CCOP, Limited Recompetition Of Cooperative Group Program, New Control Efforts

October 30, 1981

National Coalition for Cancer Research Formed To Support Reauthorization, l Research Budgets

April 19, 1985

Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval

January 27, 2006